References
- Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22
- Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53
- Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-9
- Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke. Stroke 2005;36:1115-19
- Frost L, Engholm G, Johnsen S, et al. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med 2001;161:272-6
- Vohra R, Zahrani H, Lieberman DP. Factors affecting limb salvage and mortality in patients undergoing femoral embolectomy. J R Coll Surg Edinb 1991;36:213-15
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2014. [Epub ahead of print]
- Ketha SS, McBane R, Grill D, et al. Distribution of thromboembolism in valvular compared to non-valvular atrial fibrillation. J Am Coll Cardiol 2014;63(12_S): DOI:10.1016/S0735-1097(14)60368-5
- Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004;923:1-122
- Lucas G, Tribouilloy C. Epidemiology and etiology of acquired heart valve diseases in adults. Rev Prat 2000;50:1642-5
- Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11
- Coulshed N, Epstein EJ, McKendrick CS, et al. Systemic embolism in mitral valve disease. Br Heart J 1970;32:26-34
- Szekely P. Systemic embolism prophylaxis in rheumatic heart disease. Br Med J 1964;1:1209-12
- Cohn LH, Mudge GH, Pratter F, Collins JJ Jr. Five to eight-year follow-up of patients undergoing porcine heartvalve replacement. N Engl J Med 1981;304(5):258-62
- Williams JB, Karp RB, Kirklin JW, et al. Considerations in selection and management of patients undergoing valve replacement with glutaraldehyde-fixed porcine bioprotheses. Ann Thorac Surg 1980;30(3):247-58
- Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89(2):635-41
- Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70
- Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72
- Ammash N, Konik EA, McBane RD, et al. Left atrial blood stasis and von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation. Arterioscler Thromb Vasc Biol 2011;31:2760-6
- Roy D, Marchand E, Gagne P, et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986;112(5):1039-43
- Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart 2012;97(15):1120-6
- Hart R, Pearce L, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I–III clinical trials. Stroke 1999;30:1223-9
- Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005;20:1687-91
- Wood P. An appreciation of mitral stenosis. I. Clinical features. Br Med J 1954;1(4870):1051-63; contd
- McBane RD, Hodge DO, Wysokinski WE. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost 2008;99(5):951-5